Barclays raised the firm’s price target on Encompass Health (EHC) to $118 from $116 and keeps an Overweight rating on the shares post the Q4 ...

Trust Point Inc. decreased its holdings in Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.4% in the fourth quarter, ...

Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, ...

Buying $1000 In ELV: If an investor had bought $1000 of ELV stock 20 years ago, it would be worth $6,446.06 today based on a price of $390.47 for ELV at the time of writing.

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...

Shares of healthcare companies saw an uptick in today's trading session, with Elevance Health leading the pack at a 2.2% increase, followed by Molina Healthcare (NYSE:MOH) at 4.2%, Unitedhealth at 1.6 ...